CASCADIAN THERAPEUTICS INC - COM NEW (CASC)

CUSIP: 14740B606

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
14,695,127
Share change
+13,973,579
Total reported value
$63,332,000
Put/Call ratio
46%
Price per share
$4.31
Number of holders
48
Value change
+$60,223,000
Number of buys
46

Quarterly Holders Quick Answers

What is CUSIP 14740B606?
CUSIP 14740B606 identifies CASC - CASCADIAN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM NEW (CASC) as of Q4 2016

As of 31 Dec 2016, CASCADIAN THERAPEUTICS INC - COM NEW (CASC) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,695,127 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, NEA Management Company, LLC, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Sandia Holdings, LLC, BlackRock Institutional Trust Company, N.A., and Anson Funds Management LP. This page lists 48 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.